查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968031

Yell老年診斷全球市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Yersinia Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

Yer Senior診斷市場預計將從2025年的42.2億美元成長到2034年的64.3億美元，2026年至2034年的複合年成長率為4.79%。

由於耶爾森菌屬（尤其是小腸結腸炎耶爾森菌）引起的食源性疾病數量不斷增加，全球耶爾森菌診斷市場正蓬勃發展。人們對細菌性胃腸道感染疾病的認知不斷提高，以及監測系統的完善，都促進了診斷檢測率的上升。此外，與受污染食品和水源相關的病例數量不斷增加，也進一步推動了準確、快速診斷解決方案的需求。

分子診斷技術的進步，包括基於PCR的檢測和快速免疫檢測，是成長要素。醫院和診斷檢查室擴大採用自動化系統，以實現更快、更準確的檢測。各國政府加強食品安全法規和疾病監測計畫的舉措，也促進了已開發國家和開發中國家的市場擴張。

未來幾年，就地檢驗和多重診斷平台技術的進步預計將對市場產生積極影響。數位健康技術與檢查室自動化的整合將提高效率並加快檢測結果的出具。公共衛生基礎設施和感染疾病研究投入的增加將進一步加速市場成長，預計老年診斷市場將繼續穩定擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球老年診斷市場：依檢測方法分類

  • 市場分析、洞察與預測
  • 糞便培養
  • ELISA
  • 免疫測量
  • 試管凝集法
  • 電腦斷層掃描
  • 超音波檢查
  • 大腸鏡檢查

第5章：全球 Yell 老年診斷市場：依技術分類

  • 市場分析、洞察與預測
  • PCR
  • DNA探針
  • 單株抗體
  • 免疫檢測
  • IT
  • 其他

第6章：全球 Yell 老年診斷市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Gen-Probe
    • Bio-Rad
    • Affymetrix Inc
    • Abbott Laboratories
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Qiagen
    • Becton Dickinson
    • Hologic Inc
    • PerkinElmer
簡介目錄
Product Code: VMR112110054

The Yersinia Diagnostics Market size is expected to reach USD 6.43 Billion in 2034 from USD 4.22 Billion (2025) growing at a CAGR of 4.79% during 2026-2034.

The Global Yersinia Diagnostics Market is gaining momentum due to the rising prevalence of foodborne infections caused by Yersinia species, particularly Yersinia enterocolitica. Growing awareness about bacterial gastrointestinal infections and improved surveillance systems are contributing to higher diagnostic testing rates. Increasing cases linked to contaminated food and water supplies are further driving demand for accurate and rapid diagnostic solutions.

Technological advancements in molecular diagnostics, including PCR-based testing and rapid immunoassays, are key growth drivers. Hospitals and diagnostic laboratories are adopting automated systems for faster and more precise detection. Government initiatives aimed at strengthening food safety regulations and disease monitoring programs are also supporting market expansion across both developed and developing countries.

In the coming years, the market is expected to benefit from advancements in point-of-care testing and multiplex diagnostic platforms. Integration of digital health technologies and laboratory automation will improve efficiency and turnaround times. Rising investments in public health infrastructure and infectious disease research will further accelerate growth, positioning the Yersinia diagnostics market for steady expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Types

  • Stool Culture
  • ELISA
  • Radioimmunoassay
  • Tube Agglutination
  • CT Scan
  • Ultrasonography
  • Colonoscopy

By Techniques

  • PCR
  • DNA Probes
  • Monoclonal Antibodies
  • Immunoassay
  • IT
  • Others

COMPANIES PROFILED

  • GenProbe, BioRad, Affymetrix Inc, Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Qiagen, Becton Dickinson, Hologic Inc, PerkinElmer
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL YERSINIA DIAGNOSTICS MARKET: BY TEST TYPES 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Types
  • 4.2. Stool Culture Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Radioimmunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Tube Agglutination Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. CT Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Ultrasonography Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Colonoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL YERSINIA DIAGNOSTICS MARKET: BY TECHNIQUES 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Techniques
  • 5.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. DNA Probes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. IT Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL YERSINIA DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Types
    • 6.2.2 By Techniques
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Types
    • 6.3.2 By Techniques
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Types
    • 6.4.2 By Techniques
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Types
    • 6.5.2 By Techniques
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Types
    • 6.6.2 By Techniques
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL YERSINIA DIAGNOSTICS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Gen-Probe
    • 8.2.2 Bio-Rad
    • 8.2.3 Affymetrix Inc
    • 8.2.4 Abbott Laboratories
    • 8.2.5 Roche Diagnostics
    • 8.2.6 Thermo Fisher Scientific
    • 8.2.7 Qiagen
    • 8.2.8 Becton Dickinson
    • 8.2.9 Hologic Inc
    • 8.2.10 PerkinElmer